![Christine Lemke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christine Lemke
Chairman at Acousia Therapeutics GmbH
Christine Lemke active positions
Companies | Position | Start | End |
---|---|---|---|
Acousia Therapeutics GmbH
![]() Acousia Therapeutics GmbH BiotechnologyHealth Technology Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany. | Chairman | - | - |
Career history of Christine Lemke
Training of Christine Lemke
University of Denver | Masters Business Admin |
Statistics
International
United States | 2 |
Germany | 2 |
Operational
Masters Business Admin | 1 |
Chairman | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Acousia Therapeutics GmbH
![]() Acousia Therapeutics GmbH BiotechnologyHealth Technology Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany. | Health Technology |
- Stock Market
- Insiders
- Christine Lemke
- Experience